Vicente Arrarte

Dr. Vicente Arrarte

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ACAlmudena Castro
Almudena Castro
DMDomingo Marzal Martín
Domingo Marzal Martín
RRRaquel Campuzano Ruiz
Raquel Campuzano Ruiz
MOMaria Rosa Fernández Olmo
Maria Rosa Fernández Olmo
CMCarlos Morillas
Carlos Morillas
JUAN JOSE GORGOJO-MARTINEZJUAN JOSE GORGOJO-MARTINEZ
JUAN JOSE GORGOJO-MARTINEZ
Type 2 diabetes (T2DM) is one of the main public health care problems worldwide. It is associated with a marked increased risk of developing atherosclerotic vascular disease, heart failure, chronic kidney disease and death. It is essential to act during the early phases of the disease, through the intensification of lifestyle changes and the prescription of those drugs that have been shown to reduce these complications, with the aim not only of achieving an adequate metabolic control, but also a comprehensive vascular risk control. In this consensus document, developed by the different specialists that treat these patients (endocrinologists, primary care physicians, internists, nephrologists and cardiologists), a more appropriate approach in the management of patients with T2DM or its complications is provided. A particular focus is given to the global control of cardiovascular risk factors, the inclusion of weight within the therapeutic objectives, the education of patients, the deprescription of those drugs without cardiovascular benefit, and the inclusion of GLP-1 receptor agonists and SGLT2 inhibitors as cardiovascular protective drugs, at the same level as statins, acetylsalicylic acid, or renin angiotensin system inhibitors.

MRMiguel Angel Serrano rosa
Miguel Angel Serrano rosa
EZEva León Zarceño
Eva León Zarceño
CGCristina Giglio
Cristina Giglio
Salvador Boix-VilellaSalvador Boix-Vilella
Salvador Boix-Vilella
AMAntonio Moreno-Tenas
Antonio Moreno-Tenas
Vicente ArrarteVicente Arrarte
Vicente Arrarte
The aim of this study was to investigate how physical limitations after ACS influence patients’ quality of life and health perception. This was a longitudinal clinical study. We recruited 146 patients diagnosed with ACS. The patients performed a stress test (Bruce’s protocol) for the evaluation of physical limitations and were classified according to the test result: without physical limitations (more than 10 METS), with some physical limitations (7 to 9 METS), and with high physical limitations (less than 6 METS). Significant differences were found between the three groups immediately after the diagnosis of ACS and after a period of three months, regarding health perception, anxiety, depression, sexual relationships, distress, and adjustment to disease. These differences resulted larger between the group with less limitations and the group with higher limitations. After 3 months, however, there was an overall improvement in all variables. In conclusion, physical limitations after ACS seem to influence perceived quality of life determined by measuring general health, vitality, total adaptation, emotional role, social adaptation, depression, and anxiety. Therefore, the highest the physical limitations, the poorer the psychological conditions and vice versa, even 3 months after ACS diagnosis.

20 December 2019 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
CMCristina Mitroi
Cristina Mitroi
AMA. Martín-García
A. Martín-García
PRP. Mazón Ramos
P. Mazón Ramos
JEJ. A. Virizuela Echaburu
J. A. Virizuela Echaburu
MAM. Arenas-Prat
M. Arenas-Prat
TLT. López-Fernández
T. López-Fernández

1 March 2016 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
ACAlmudena Castro Conde
Almudena Castro Conde
DMDomingo Marzal Martín
Domingo Marzal Martín
RGRegina Dalmau González-Gallarza
Regina Dalmau González-Gallarza
Vicente ArrarteVicente Arrarte
Vicente Arrarte
MBMiren Morillas Bueno
Miren Morillas Bueno
MAManuel Abeytua
Manuel Abeytua

Verified
Journal Article
Open access
PDF file
ALAdriana Lopez-Pineda
Adriana Lopez-Pineda
CMCristina Soriano Maldonado
Cristina Soriano Maldonado
Vicente ArrarteVicente Arrarte
Vicente Arrarte
FFFrancisco Jose Sánchez Ferrer
Francisco Jose Sánchez Ferrer
VBVicente Bertomeu-Gonzalez
Vicente Bertomeu-Gonzalez
Alberto CorderoAlberto Cordero
Alberto Cordero
Current cardiovascular prevention guidelines emphasise considering sex, gender, and gender identity in risk assessment. This study evaluated the impact of lifestyle habits and chronic diseases on cardiovascular mortality risk in women over 50 with high vascular risk and developed a predictive model for menopausal women with cardiovascular risk factors. A retrospective cohort study used data from the 2011 Spanish National Health Survey and the national death register, focusing on menopausal and postmenopausal women without prior cardiovascular events but with at least one major risk factor. Participants were followed for up to 10 years, assessing mortality from circulatory system diseases and other causes. Exposure variables included socio-demographics, lifestyle habits, health status, self-perceived health, health service use, and pharmacological treatments. Of the 21,007 respondents, 3057 women met the inclusion criteria. The 10-year cumulative incidence of mortality from circulatory causes was 5.9%, and from other causes, 12.7%. Independent predictors of cardiovascular mortality were never consuming legumes, poor self-perceived health, diabetes treatment, lack of physical activity, and older age. Lipid-lowering treatment was protective. The model demonstrated good fit and predictive capacity (C-index = 0.773). This study highlights the significant influence of physical activity, legume consumption, self-perceived health, and specific treatments on cardiovascular mortality risk in menopausal women.

Alberto CorderoAlberto Cordero
Alberto Cordero
Vicente ArrarteVicente Arrarte
Vicente Arrarte
MSMiriam Sandín
Miriam Sandín
OMOscar Moreno-Perez
Oscar Moreno-Perez
EPEmilio Flores Pardo
Emilio Flores Pardo
The worse nutritional status of patients without obesity after an acute coronary syndrome (ACS) could explain their worse prognosis and the so-called obesity paradox. We performed a retrospective study of all consecutive patients admitted to a hospital for ACS between 2009 and 2020. Nutritional status was analyzed using the CONUT scale, and values > 4 were categorized as moderate-severe malnutrition. We included 2789 patients with a mean BMI of 28.0 (4.6) kg/m2 and 26.4% with obesity. The mean CONUT index was 2.4 (2.2), and 24.3% had moderate-severe malnutrition. Obese patients had a lower prevalence of moderate-severe malnutrition: 20.0% vs. 25.9% (p = 0.003). The median follow-up was 3 years. A significant interaction between BMI and the CONUT for mortality was verified, and both variables behaved in the opposite way in relation to risk. BMI was associated with lower all-cause (HR: 0.93, 95% CI 0.89–0.98) and cardiovascular (HR: 0.93, 95% CI 0.87–0.98) mortality risk only in patients with CONUT > 4; however, in patients without malnutrition, BMI obesity was not associated with increased mortality or major cardiovascular events. In conclusion, CONUT-defined nutritional-inflammatory status may partly contribute to the observed obesity paradox in ACS patients.